Health Care & Life Sciences » Pharmaceuticals | Zynerba Pharmaceuticals Inc.

Zynerba Pharmaceuticals Inc.

Zynerba Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
17.62 M
Public Float
11.46 M
Zynerba Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.27
Market Cap
$325.4 M
Shares Outstanding
21.07 M
Public Float
14.68 M

Profile

Address
80 West Lancaster Avenue
Devon Pennsylvania 19333
United States
Employees -
Website http://zynerba.com
Updated 07/08/2019
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It engages in the development and commercialization of transdermal pharmaceutically-produced cannabinoid treatments for rare and near-rare neurological and psychiatric, or neuropsychiatric, disorders in patients with high unmet medical needs. The company was founded by Audra L.

Financials

View All

Armando Anido
Chairman & Chief Executive Officer
John P. Butler
Director